Psychedelics have entered the mainstream, informing a multimillion dollar industry – but the majority of healthcare providers working directly with patients are unaware of the growing field of psychedelic therapy. The newly formed Psychedelic Medicine Association (PMA) remedies this with a collaborative platform created for medical professionals, organizations, and drug developers to educate and guide each other over emerging science, ethics and cultural issues in this rapidly developing field.